Cholesterol Metabolism and Brain Amyloidosis: Evidence for a Role of Copper in the Clearance of A &bgr; Through the Liver

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|4|2|165-169

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.4, Iss.2, 2007-04, pp. : 165-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Mounting evidence suggests that copper may influence the progression of Alzheimer's disease by reducing clearance of the amyloid beta protein (Aß) from the brain. We propose that A&bgr; is cleared from the brain by tagging along with cholesterol/ApoE in traversing the BBB, with subsequent incorporation into HDL for delivery of the toxin to the liver. It is suggested that either ABC-A1 or LRP, or both are involved in A&bgr; transport across the BBB, as well as normal cholesterol efflux. We have previously shown that addition of only 0.12 PPM copper (one-tenth the Environmental Protection Agency Human consumption limits) to distilled water was sufficient to precipitate the accumulation of Aß in the brains of cholesterol-fed rabbits. Here we show that in a setting of elevated cholesterol levels, overproduced A&bgr; is cleared to the blood and can simultaneously be identified in the liver if copper ion is absent from the animal's drinking water, but if trace levels copper (0.12 PPM) are added to the drinking water A&bgr; accumulates in the brain, while the levels in the liver are greatly reduced.